XEL
65
-2
PX
73
-6
VNO
60
8
RCL
88
-2
WMB
68
-2
NRG
50
-2
SHW
70
2
BAX
27
-2
DOV
73
4
DUK
50
-2
DTE
38
-4
TROW
51
-2
BMY
61
-3
IVZ
49
-3
PG
50
2
ALLE
41
-7
SE
60
-5
DVN
29
4
FTI
78
-3
R
77
2
XEL
65
-2
PX
73
-6
VNO
60
8
RCL
88
-2
WMB
68
-2
NRG
50
-2
SHW
70
2
BAX
27
-2
DOV
73
4
DUK
50
-2
DTE
38
-4
TROW
51
-2
BMY
61
-3
IVZ
49
-3
PG
50
2
ALLE
41
-7
SE
60
-5
DVN
29
4
FTI
78
-3
R
77
2
Financhill
Back

Franco-Nevada 10K Form

Sell
22

FNV.TO
Franco-Nevada

Last Price:
161.97
Seasonality Move:
4.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FNV.TO News And Ratings

See the #1 stock for the next 7 days that we like better than FNV.TO

FNV.TO Financial Statistics

Sales & Book Value

Annual Sales: $1.65B
Cash Flow: $-35.91M
Price / Cash Flow: 59.86
Annual Sales: $42.01
Price / Book: 3.86

Profitability

EPS (TTM): -4.31960
Net Income (TTM): $-825.49M
Gross Margin: $1.03B
Return on Equity: -10.11%
Return on Assets: -9.7%

Franco-Nevada Earnings Forecast

Key Franco-Nevada Financial Ratios

  • The Gross Profit Margin over the past 17 years for FNV.TO is 62.89%.
  • The Selling, General & Administrative Expenses for FNV.TO have been equal to 2.37% of Gross Profit Margin.
  • The Research & Development expenses have been 0.53% of Revenue.
  • The Interest Expense is -0.02% of Operating Income.
  • The Net Earning history of FNV.TO is -38.26% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 8 years.

Franco-Nevada Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: TSX
Industry: Metals & Mining
Sector: Materials
Current Symbol: FNV.TO
Website: franco-nevada.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 23.39
Quick Ratio: 21.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 29.24

FNV.TO Technical Analysis vs Fundamental Analysis

Sell
22
Franco-Nevada (FNV.TO) is a Sell

Is Franco-Nevada a Buy or a Sell?

  • Franco-Nevada stock is rated a Sell
    The current Franco-Nevada [FNV.TO] share price is $161.97. The Score for FNV.TO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.